Xiaoping Zhang
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Renal cell carcinoma treatment 56
- Prostate Cancer Treatment and Research 12
- Ferroptosis and cancer prognosis 11
-
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 13
- Cancer, Lipids, and Metabolism 12
- Cancer, Hypoxia, and Metabolism 12
- Co-authors
- Hongmei Yang (63 shared papers)Hailong Ruan (34 shared papers)Ke Chen (30 shared papers)Wen Xiao (34 shared papers)Gabriel J. Robbie (1 shared paper)Wolf‐Dietrich Heyer (2 shared papers)Huageng Liang (25 shared papers)Tianbo Xu (23 shared papers)
- Journals
- Cell Death and Disease (8 papers)Frontiers in Oncology (7 papers)Experimental Cell Research (6 papers)Frontiers in Genetics (5 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoping Zhang
237 papers receiving 10.3k citations
Xiaoping Zhang's Hit Papers
Peers
Comparison fields: 5 of 149
- Infectious Diseases 2.3k
- Cancer Research 1.3k
- Nephrology 598
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 689
Countries citing papers authored by Xiaoping Zhang
This map shows the geographic impact of Xiaoping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Zhang more than expected).
Fields of papers citing papers by Xiaoping Zhang
This network shows the impact of papers produced by Xiaoping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Zhang. The network helps show where Xiaoping Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Hit paper breakdown → | 2020 | 3053 |
| 2 | Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury Hit paper breakdown → | 2020 | 435 |
| 3 | 2020 | 377 | |
| 4 | 2009 | 361 | |
| 5 | 2016 | 264 | |
| 6 | 2014 | 249 | |
| 7 | 2006 | 206 | |
| 8 | 2019 | 188 | |
| 9 | 2016 | 155 | |
| 10 | 2015 | 136 | |
| 11 | 2014 | 128 | |
| 12 | 2021 | 115 | |
| 13 | 2020 | 100 | |
| 14 | 2007 | 95 | |
| 15 | 2020 | 92 | |
| 16 | 1995 | 91 | |
| 17 | 2012 | 88 | |
| 18 | 2007 | 84 | |
| 19 | 2013 | 83 | |
| 20 | 2017 | 83 |
About Xiaoping Zhang
Xiaoping Zhang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Nephrology and Oncology, having authored 243 papers that have together received 10.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (56 papers), MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (13 papers), Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (12 papers), Cancer, Hypoxia, and Metabolism (12 papers), Ferroptosis and cancer prognosis (11 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Cancer Research (1.3k citations), Nephrology (598 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Oncology (689 citations). Xiaoping Zhang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hongmei Yang, Hailong Ruan, Ke Chen, Wen Xiao, Gabriel J. Robbie, Wolf‐Dietrich Heyer, Huageng Liang, Tianbo Xu, Zhiyong Xiong and Lin Bao. Their work appears in journals such as Cell Death and Disease, Frontiers in Oncology, Experimental Cell Research, Frontiers in Genetics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.